Adenosine triphosphate affects interleukin -1β release by T98G glioblastoma cells through a purinoceptor-independent mechanism

Neuroscience Letters

Volumn 285, Issue 3, 2000, Pages 218-222

  de Joannon, Alessandra Capezzone ^a   Mancini, Francesca ^a   Landolfi, Carla ^a   Soldo, Lucia ^a   Leta, Aida ^b   Ruggieri, Alessandro ^a   Mangano, Giorgina ^a   Polenzani, Lorenzo ^a   Pinza, Mario ^a   Milanese, Claudio ^a  

^a Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Adenosine triphosphate; Interleukin 1 ; P2 purinoceptor; T98G glioblastoma cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; GRAMICIDIN; INTERLEUKIN 1BETA; PURINE P2 RECEPTOR; PURINE RECEPTOR; SURAMIN; VALINOMYCIN;

ARTICLE; CYTOKINE RELEASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MICROGLIA; PRIORITY JOURNAL; PROTEIN PROCESSING;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; INTERLEUKIN-1; MEMBRANE POTENTIALS; RECEPTORS, PURINERGIC P2; SURAMIN; TUMOR CELLS, CULTURED;

EID: 0034685697     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01051-X     Document Type: Article

References (17)

1. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA. 89:1992;10075-10078.
2. Charlton S.J., Brown C.A., Weisman G.A., Turner J.T., Erb L., Boarder M.R. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br. J. Pharmacol. 118:1996;704-710.
3. Chin J., Kostura M.J. Dissociation of IL-1β synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products. J. Immunol. 151:1993;5574-5585.
4. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1994;1314-1325.
5. Ferrari D., Chiozzi P., Falzoni S., Hanau S., Di Virgilio F. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185:1997;579-582.
6. Ferrari D., Villalba M., Chiozzi P., Falzoni S., Ricciardi-Castagnoli P., Di Virgilio F. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156:1996;1531-1539.
7. Foresta C., Rossato M., Bordon P., Di Virgilio F. Extracellular ATP activates different signalling pathways in rat Sertoli cells. Biochem. J. 311:1995;269-274.
8. Griffiths R.J., Stam E.J., Downs J.T., Otterness I.G. ATP induces the release of IL-1 from LPS-primed cells in vivo. J. Immunol. 154:1995;2821-2828.
9. Hourani S.M.O., Chown J.A. The effects of some possible inhibitors of ectonucleotidase on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen. Pharmacol. 20:1989;413-416.
10. Landolfi C., Soldo L., Polenzani L., Apicella C., Capezzone de Joannon A., Coletta I., Di Cesare F., Brufani M., Pinza M., Milanese C. Inflammatory molecule release by β-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol. Eur. J. Pharmacol. 360:1998;55-64.
11. Perregaux D., Gabel C.A. Interleukin-1β maturation and release in response to ATP and nigericin: evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269:1994;15195-15203.
12. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II: actions and mechanism of action. Trends Neurosci. 18:1995;130-136.
13. Sharif S.F., Hariri R.J., Chang V.A., Barie P.S., Wang R.S., Ghajar J.B. Human astrocyte production of tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6 following exposure to lipopolysaccharide endotoxin. Neurol. Res. 15:1993;109-112.
14. Tanner M.K., Wellhausen S.R., Klein J.B. Flow cytometric analysis of altered mononuclear cell transmembrane potential induced by cyclosporin. Cytometry. 14:1993;59-69.
15. Thornberry N.A. Intrleukin-1β converting enzyme. Methods Enzymol. 244:1994;615-631.
16. Wilson K.P., Black J.F., Thomson J.A., Kim E.E., Griffith J.P., Navia M.A., Murcko M.A., Chambers S.P., Aldape R.A., Raybuck S.A., Livingston D.J. Structure and mechanism of interleukin-1β-converting enzyme. Nature. 370:1994;270-275.
17. Zimmermann H. Signalling via ATP in the nervous system. Trends Neurosci. 17:1994;420-426.